Dr. Jürgen Schumacher is a Co-Founder of Algiax Pharmaceuticals and serves as its Advisor. Jürgen Schumacher is one of Germany's leading biotech entrepreneurs with more than 20 years' experience in the industry. He sits on the boards of many companies but mostly those involved in the biotech industry. Jürgen was co-founder of Qiagen and acted as spokesperson for the board. He has founded many companies in Germany including NewLab BioQuality which was recently sold to a large US company. Moreover, he is a member of numerous biotech associations and is a consultant for the biotechnology activities in North Rhine Westphalia. He also serves as the CEO of SCT Spinal Cord Therapeutics.